FDA Approved: BOSENTAN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved Zydus Pharmaceuticals USA Inc.'s supplemental application for Bosentan, authorizing a generic version of the drug in the U.S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Bosentan (Bosentan)

Snippet

SUPPL AP for BOSENTAN (BOSENTAN)